VRSN
53
-4
SLB
55
2
PYPL
54
2
TGT
22
2
NRG
49
-3
FITB
63
3
EQT
57
-2
USB
55
-6
HAS
33
3
WM
79
3
GIS
31
3
UNP
52
7
MPC
44
-3
HPE
63
2
RSG
71
3
INTC
33
-2
DG
6
2
PM
62
-2
CSCO
67
4
NTAP
67
-3
VRSN
53
-4
SLB
55
2
PYPL
54
2
TGT
22
2
NRG
49
-3
FITB
63
3
EQT
57
-2
USB
55
-6
HAS
33
3
WM
79
3
GIS
31
3
UNP
52
7
MPC
44
-3
HPE
63
2
RSG
71
3
INTC
33
-2
DG
6
2
PM
62
-2
CSCO
67
4
NTAP
67
-3
Financhill
Back

Range Cancer Therapeutics ETF Vs. Virtus LifeSci Biotech Clinical Trls ETF Industry Stock Comparison

Sell
47

CNCR
Range Cancer Therapeutics ETF

Last Price:
13.62
Seasonality Move:
2.55%
Sell
35

BBC
Virtus LifeSci Biotech Clinical Trls ETF

Last Price:
26.53
Seasonality Move:
8.49%
Sell
47
Range Cancer Therapeutics ETF (CNCR) is a Sell

Is Range Cancer Therapeutics ETF a Buy, Sell or Hold?

  • The current Range Cancer Therapeutics ETF [CNCR] share price is $13.56. The Score for CNCR is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
  • CNCR is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
35
Virtus LifeSci Biotech Clinical Trls ETF (BBC) is a Sell

Is Virtus LifeSci Biotech Clinical Trls ETF a Buy, Sell or Hold?

  • The current Virtus LifeSci Biotech Clinical Trls ETF [BBC] share price is $26.85. The Score for BBC is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
  • BBC is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

CNCR Stock Price Chart

What is Range Cancer Therapeutics ETF's stock price today?

  • The Range Cancer Therapeutics ETF share price today is $13.56
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CNCR is experiencing slight buying pressure.

BBC Stock Price Chart

What is Virtus LifeSci Biotech Clinical Trls ETF's stock price today?

  • The Virtus LifeSci Biotech Clinical Trls ETF share price today is $26.85
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BBC is experiencing selling pressure, which indicates risk of future bearish movement.

CNCR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.43 Sell
Relative Strength Index (14 RSI): 36.72 Sell
Chaikin Money Flow: 1180 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (13.87 - 15.47) Sell
Bollinger Bands (100): (14.08 - 15.46) Sell

BBC Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.71 Sell
Relative Strength Index (14 RSI): 39.14 Sell
Chaikin Money Flow: -1940 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (27.28 - 30.42) Sell
Bollinger Bands (100): (26.74 - 29.5) Sell

CNCR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 13.68 Sell
20-day SMA: 14.6 Sell
50-day SMA: 14.86 Sell
200-day SMA: 15.05 Sell
8-day EMA: 13.76 Sell
20-day EMA: 14.32 Sell
50-day EMA: 14.66 Sell
200-day EMA: 14.55 Sell

BBC Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 26.97 Sell
20-day SMA: 28.68 Sell
50-day SMA: 28.66 Sell
200-day SMA: 27.79 Sell
8-day EMA: 27.12 Sell
20-day EMA: 28.12 Sell
50-day EMA: 28.4 Sell
200-day EMA: 27.24 Sell

Range Cancer Therapeutics ETF Earnings Growth & CNCR Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Virtus LifeSci Biotech Clinical Trls ETF Earnings Growth & BBC Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Range Cancer Therapeutics ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Virtus LifeSci Biotech Clinical Trls ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):